819 Induction carboplatin-paclitaxel-gemcitabine (CPG) followed by concurrent weekly carboplatin-paclifaxel (CP) and radiation therapy in unresectable stage iii non-small cell lung cancer (NSCLC). A phase II study
2003 ◽
Vol 1
(5)
◽
pp. S246
Keyword(s):
Phase Ii
◽